{"database": "lobbying", "table": "lobbying_activities", "rows": [[1116881, "918dea0c-bfcd-4440-9aed-87dd6af1a03a", "Q2", "BROWN RUDNICK LLP", 287895, "HEALTHCARE DISTRIBUTION ALLIANCE F/K/A HEALTHCARE DISTRIBUTION MANAGEMENT ASSOC", 2011, "second_quarter", "PHA", "Issues related to supply chain safety and DEA drug; H.R. 147 & S. 319 Pharmaceutical Market Access and Drug Safety Act; H.R. 866 - National All schedules Prescription Reporting Reauthorization Act of 2011; H.R. 1065 - Pill Mill Crackdown Act of 2011; S. 507 - Prescription Drug Abuse , Prevention and Treatment Act of 2011; H.R. 2245 & S. 296 - Preserving Access to Life-Saving Medication Act of 2011\nS. 1002 - Safe Doses Act", "HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2011-07-18T11:22:23.837000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1116881"], "units": {}, "query_ms": 0.5806040135212243, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}